| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $696K | — | -97.2% |
| R&D Expense | $72.1M | — | +23.2% |
| SG&A Expense | $15.2M | — | +9.9% |
| Operating Income | -$87.2M | — | -78.6% |
| Income Tax | -$50K | — | — |
| Net Income | -$84.8M | — | -87.7% |
| EPS (Basic) | -$0.99 | — | -52.3% |
| EPS (Diluted) | -$0.99 | — | -52.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $77.7M | -23.7% | -8.7% |
| Short-term Investments | $144.8M | -29.1% | -37.8% |
| Accounts Receivable | $1.2M | +77.7% | +161.8% |
| Inventory | $1.3M | -31.1% | -41.3% |
| Current Assets | $249.5M | -24.1% | -23.7% |
| Total Assets | $288.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$80.5M | — | -51.6% |
| Capital Expenditures | $997K | — | +261.2% |
| Investing Cash Flow | $59.1M | — | +49.4% |
| Financing Cash Flow | -$2.6M | — | -174.9% |
| Free Cash Flow | -$81.5M | — | -52.7% |
| -20.5% |
| Current Liabilities | $37.5M | +1.2% | -10.1% |
| Total Liabilities | $57.7M | -0.2% | -10.0% |
| Stockholders' Equity | $230.5M | -24.7% | -22.8% |